Clinical Pharmacokinetics of Lamivudine
- 1 January 1999
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 36 (1), 41-66
- https://doi.org/10.2165/00003088-199936010-00004
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Single dose pharmacokinetics of lamivudine in subjects with impaired renal function and the effect of haemodialysisBritish Journal of Clinical Pharmacology, 1998
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- LamivudineDrugs, 1997
- Interaction between lamivudine (3TC) and other nucleoside analogues for intracellular phosphorylationAIDS, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II StudyThe Journal of Infectious Diseases, 1995
- Clinical Pharmacokinetics Of Nucleoside Antiretroviral AgentsThe Journal of Infectious Diseases, 1995
- Determination of 2′-deoxy-3′-thiacytidine (3TC) in human urine by liquid chromatography: direct injection with column switchingJournal of Pharmaceutical and Biomedical Analysis, 1994
- Pharmacokinetics of Stavudine in Patients with AIDS or AIDS-Related ComplexThe Journal of Infectious Diseases, 1992